CRP and Insulin resistance: Finally, the IRAS, showed that high CRP baseline levels (>2.4 mg/L) amongst patients diagnosed with insulin resistance were associated with a higher risk of developing T2D [39] and recognized a significant correlation between CRP and components of insulin resistance [38].